Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase II open-label lapatinib in advanced breast cancer with HER2-non-amplified primary tumors and HER2- or EGFR-positive circulating tumor cells
2007-002155-17Phase 2Completed
- Sponsor
- GSK
- Start
- Aug 2007
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of lapatinib in breast cancer, sponsored by GSK. Primary endpoint: Overall response rate. Started Aug 2007; status: completed.
02
Drugs
lapatinib
03
Conditions
breast cancer
Beyond the preview
Go deeper on 2007-002155-17.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2007-002155-17.